Responses

Download PDFPDF
The 10-year follow-up of a randomised trial of long-chain polyunsaturated fatty acid supplementation in preterm infants: effects on growth and blood pressure
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Long-term health consequences of LCPUFA supplementation of preterm girls

    Editor:

    Caregivers of preterm infants and children are not well served by the report of Kennedy et al.,[1] "Girls who were born preterm and received LCPUFA supplemented formula showed increased weight, adiposity and BP at 10 years, with potential consequences for later health." LCPUFA supplementation programming preterm girls to later obesity and hypertension is not supported by their data. The issue is height:...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Reply to letters from Dr J Hoffman and Dr A Lapillone

    Dear Sir

    Response to letter from James P Hoffman of Martek Biosciences Corp.

    We completely disagree with Dr Hoffman's statement that "caregivers of preterm infants are not well served by our report of a 10 year follow-up of LCPUFA supplementation in preterm infants". Our study (1) presents the results of the longest follow-up of a randomised trial LCPUFA supplementation during infancy to date. We have...

    Show More
    Conflict of Interest:
    None declared.